Trial intelligence / Profile preview

Postoperative pulmonary function after sugammadex vs neostigmine in laparoscopic sleeve gastrectomy

2014-005116-41Phase 4Active

Sponsor
Università di Padova
Start
Apr 2015
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in obesity and neuromuscular block (NMB) comparing Sugammadex arm with Neostigmine arm (2 arms). Primary endpoint: Timing of reversal from neuromuscular blockade. Started Apr 2015; status: active.

02

Drugs

Sugammadexneostigmine
03

Conditions

obesityneuromuscular block (NMB)

Beyond the preview

Go deeper on 2014-005116-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-005116-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call